<p>The UK SMA Patient Registry
(https://www.treat-nmd.org.uk/registry/) is a joint venture between the John
Walton Muscular Dystrophy Research Centre at Newcastle University and the
patient group SMA UK (formerly known as the Jennifer Trust, then SMA Support
UK). SMA UK is a UK national charity dedicated to supporting people affected by
SMA and investing in essential research into causes, treatments and eventually
a cure for the condition. The UK SMA Patient Registry is affiliated with the
TREAT-NMD Alliance which is an organisation experienced in the design and
implementation of rare disease registries.</p><p><br></p>
<p>The purpose of the UK SMA Patient Registry is to
register SMA patients from the UK and Ireland so that they may be considered
for relevant clinical trials, receive the most up-to-date information regarding
standards of care for their disease and help provide the research community
with an understanding of SMA prevalence. Anonymised data from patients who
register in the UK SMA Patient Registry will also be shared with TREAT-NMD as
part of its global network of national SMA registries.</p><p><br></p>
<p>The registry dataset includes patient reported
clinical and genetic confirmation of SMA, symptoms relating to muscle weakness,
motor function, medication use, family history and ethnicity. This includes the
TREAT-NMD Expanded Core Dataset which includes relevant post-marketing
surveillance data items too.</p><p><br></p>
<p>All patients with a confirmed SMA diagnosis (or
pending diagnosis) are eligible for inclusion.<b></b></p>